Navigation Links
Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services
Date:4/8/2008

SWARTZ CREEK, Mich., April 8, 2008 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced Mike Maynard has joined the company as Director of National Accounts. Maynard reports directly to Dr. Atheer Kaddis, Vice President of Managed Markets.

Maynard is responsible for the development and national expansion of Diplomat's disease management programs, focusing initially on chronic kidney disease, dialysis, and renal transplant. Diplomat's disease management programs, through direct patient contact and coordination with physicians, improve access, tolerance, and compliance to appropriate medication therapy resulting in improved patient outcomes.

"Diplomat Specialty Pharmacy is very excited to welcome Mike Maynard to our team," said Kaddis. "He will lead our efforts in working with providers, employer groups and managed care organizations to further expand our best in class disease management programs focusing on chronic kidney disease, dialysis, and renal transplant. Mike will help Diplomat become a national leader in caring for patients with kidney disease."

"After spending many years in the renal marketplace, I am very excited to join the team at Diplomat Specialty Pharmacy," said Maynard. "Disease Management programs and initiatives can stem progression of disease, improve medication adherence, control costs and improve quality of life. Diplomat's CKD Navigator Program, as well as the Dialysis and Transplant Programs, are the most comprehensive and innovative programs available. I look forward to being a part of the great things that are happening at Diplomat Specialty Pharmacy."

Maynard's fifteen years as an executive in the pharmaceutical industry include extensive experience in sales, sales management and training, and Regional and National Account Management. Immediately before joining Diplomat Specialty Pharmacy, he served as an Integrated Delivery Network/Renal Account Manager with Roche Pharmaceuticals. In addition, he has over eight years of experience in the renal marketplace with Sigma-Tau Pharmaceuticals, and brings extensive experience in contract negotiation, and developing and implementing sales/marketing strategies with dialysis providers and renal Group Purchasing Organizations. Maynard holds a Bachelor of Business Administration degree from Western Michigan University, Kalamazoo, MI.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns

kkarns@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
2. American Specialty Health and INSPIRIS Win Top Honors in URACs Best Practices in Consumer Empowerment and Protection Awards
3. Zero Patient Infections Reported as D.I.S.C. Spine and Sports Center Sets New Standard for Specialty Hospitals
4. EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
5. MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative
6. Specialty Underwriters Alliance, Inc. Reports 2007 Fourth Quarter and Full Year Results
7. Relax The Back Announces Record Growth in 2007; Executives Bullish on Specialty Retailers Prospects for 2008
8. Specialty European Pharma launches plenaxis in Germany
9. Darwin Enters into Marketing Partnership with Agency Specialty Product Network
10. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
11. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: